NEW YORK, April 23, 2014 /PRNewswire/ -- Genpact Ltd.
(NYSE: G), a global leader in transforming and running business
processes and operations, today announced it has signed a
definitive agreement to acquire Pharmalink Consulting, a leading
global provider of regulatory services to the life sciences
industry for more than 15 years.
The acquisition will complement Genpact's portfolio of services
in the Life Sciences vertical and add significant consulting,
outsourcing and operations capabilities. With an ever-changing
regulatory and commercial environment, the life sciences industry
continues to face new challenges that require them to rely
increasingly on experienced providers. It also significantly
expands Genpact's capabilities in supporting the life sciences
research and development functions, including regulatory strategy,
filing submissions, complex compliance services and the management
of post-licensing activities.
Pharmalink's specialised domain expertise, speed, responsiveness
and ability to scale have made it a leading provider for
sustainable outsourcing of regulatory affairs services. Their
clients include nearly all of the twenty largest global life
sciences companies. Their specialized expertise includes the
end-to-end range of regulatory services including strategy,
chemistry manufacturing & controls (CMC),
regulatory operations and publishing & technology
services.
"This acquisition fits in exactly with our strategy to invest in
solutions in specific growth areas in specific verticals such as
Life Sciences," said NV 'Tiger' Tyagarajan, President and
CEO, Genpact. "In an industry that's undergoing
intense transformation, adding Pharmalink's combination of talent,
process expertise and domain knowledge to Genpact's portfolio will
allow us to better serve our life sciences clients."
"Genpact will bring the global scale, process excellence,
analytical insights and technology needed to further enhance our
outsourcing services offering demanded by the market,"
said Peter Griffin, Chairman, Pharmalink
Consulting. "This combination will allow us to
deliver more end-to-end regulatory affairs solutions based on
Genpact's proprietary Smart Enterprise Processes SEPSM
methodology."
Gary Charbonneau, Vice
President of Global Regulatory Affairs at Allergan adds, "The
combination of Genpact and Pharmalink is very exciting not just for
me as a client, but for the industry at large. To have the deep
experience and reputation of Pharmalink within the Regulatory
Affairs arena allied to the scale and process excellence of Genpact
is a compelling proposition."
As part of the transaction, Pharmalink's employees based in the
US, the UK, India, Ireland and Puerto
Rico will become part of Genpact's Life Sciences
vertical.
About Genpact
Genpact Limited (NYSE: G) is a global
leader in transforming and running business processes and
operations, including those that are complex and
industry-specific. Our mission is to help clients become more
competitive by making their enterprises more intelligent through
becoming more adaptive, innovative, globally effective and
connected to their own clients. Genpact stands for Generating
Impact – visible in tighter cost management as well as better
management of risk, regulations and growth for hundreds of
long-term clients including more than 100 of the Fortune Global
500. Our approach is distinctive – we offer an unbiased, agile
combination of smarter processes, crystallized in our Smart
Enterprise Processes (SEPSM) proprietary framework,
along with analytics and technology, which limits upfront
investments and enhances future adaptability. We have global
critical mass – 64,000+ employees in 24 countries with key
management and corporate offices in New
York City – while remaining flexible and collaborative, and
a management team that drives client partnerships
personally. Our history is unique – behind our single-minded
passion for process and operational excellence is the Lean and Six
Sigma heritage of a former General Electric division that has
served GE businesses for more than 15 years. For more
information, visit www.genpact.com.
Contacts
Media:
Jason Thorne, +1 212 880 5251
Jason.Thorne@ogilvy.com
Logo -
http://photos.prnewswire.com/prnh/20120501/NY98560LOGO
SOURCE Genpact Ltd.